Pregnancy Outcomes in Patients with Psoriatic Arthritis

Conclusion

The risk of preterm birth and cesarean delivery were increased in pregnant women with PsA, associated with exposure to anti-rheumatic treatment during pregnancy, especially biologic treatments. Because parity influences the risk of preterm birth in women with PsA, special attention to first pregnancies is warranted. Women with PsA should receive individualized monitoring during pregnancy.

For full study details, including source material, refer to the full article.

Excerpted and adapted from:

Remaeus K, Johansson K, Granath F, et al. Pregnancy outcomes in women with psoriatic arthritis in relation to presence and timing of antirheumatic treatment. Arthritis Rheumatol. 2022 Mar;74(3):486–495.